4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-26-032922
Director acquired 34,819 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Gautam Director | 2026-05-07 | Option exercise | +34,819 | 1,643,963 | D | ||
| Derivatives | |||||||
| Patel Gautam Director | 2026-05-07 | Option exercise · Restricted Stock Units | −34,819 | 0 | D | ||
| Patel Gautam Director | 2026-05-06 | Grant or award · Restricted Stock Units | +19,824 | 19,824 | D | ||
Loading xslF345X06/wk-form4_1778272004.xml…